C
TransMedics Group, Inc. TMDX
$124.78 -$3.72-2.90% NASDAQ
Recommendation
Prev Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
52-Week Range
P/E (TTM)
EPS (TTM)

06/30/2025 03/31/2025 12/31/2024 09/30/2024 06/30/2024
Revenue 48.09% 64.43% 82.74% 109.09% 137.47%
Total Other Revenue -- -- -- -- --
Total Revenue 48.09% 64.43% 82.74% 109.09% 137.47%
Cost of Revenue 51.56% 77.26% 105.03% 151.11% 201.48%
Gross Profit 45.85% 56.70% 70.08% 87.58% 108.78%
SG&A Expenses 24.60% 36.78% 43.44% 44.56% 53.11%
Depreciation & Amortization -- -- -- -- --
Other Operating Expenses -- -- -- -- --
Total Operating Expenses 37.65% 54.55% 67.56% 81.35% 98.53%
Operating Income 169.55% 250.24% 7,631.13% 407.01% 285.46%
Income Before Tax 4,906.22% 529.61% 234.15% 187.70% 108.36%
Income Tax Expenses 259.87% 176.41% 119.23% 101.10% -2,271.43%
Earnings from Continuing Operations 2,288.73% 580.13% 241.70% 191.22% 116.87%
Earnings from Discontinued Operations -- -- -- -- --
Extraordinary Item & Accounting Change -- -- -- -- --
Minority Interest in Earnings -- -- -- -- --
Net Income 2,288.73% 580.13% 241.70% 191.22% 116.87%
EBIT 169.55% 250.24% 7,631.13% 407.01% 285.46%
EBITDA 134.31% 183.01% 560.98% 1,114.64% 509.14%
EPS Basic 2,410.18% 564.23% 239.32% 189.85% 114.87%
Normalized Basic EPS 134.92% 178.26% 1,306.25% 437.77% 270.93%
EPS Diluted 5,763.75% 494.65% 230.87% 184.64% 105.83%
Normalized Diluted EPS 112.95% 162.11% 1,385.08% 418.71% 261.50%
Average Basic Shares Outstanding 2.69% 2.54% 2.19% 1.96% 3.22%
Average Diluted Shares Outstanding 10.68% 9.01% 7.04% 8.04% 7.65%
Dividend Per Share -- -- -- -- --
Payout Ratio -- -- -- -- --